{"id":"tp-55908","type":"article-newspaper","title":"Zealand Pharma Sees $400 Million Net Q4 Cash Inflow Tied to Roche","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/55908","datePublished":"2026-11-12T21:12:37.000Z","dateModified":"2026-11-12T21:12:37.000Z","language":"en","abstract":"A $575 million development milestone is partly offset by a $175 million payment associated with enicepatide. The 2026 operating expense range excludes other operating items.","section":"Business","references":[]}